Skip to content
lifestyle.duovoltart.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Anteris Technologies Global Corp.
Anteris Advances Global PARADIGM Trial Expansion with German Regulatory Clearance
October 19, 2026
Anteris to Present at September Healthcare Investor Conferences
August 31, 2026
Anteris Technologies Announces Results for the Second Quarter of 2026
August 11, 2026
Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance
June 8, 2026
Anteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM Trial
May 5, 2026
Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial
April 28, 2026
Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises
January 23, 2026
Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic
January 20, 2026